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Abstract
Background: Xylopia aethiopica, a plant found throughout West Africa, has both nutritional and medicinal uses.
The present study aims to characterize the effects of extracts of this plant on cancer cells.
Results: We report that X. aethiopica extract prepared with 70% ethanol has antiproliferative activity against a
panel of cancer cell lines. The IC50 was estimated at 12 μg/ml against HCT116 colon cancer cells, 7.5 μg/ml and >
25 μg/ml against U937 and KG1a leukemia cells, respectively. Upon fractionation of the extract by HPLC, the active
fraction induced DNA damage, cell cycle arrest in G1 phase and apoptotic cell death. By using NMR and mass
spectrometry, we determined the structure of the active natural product in the HPLC fraction as ent-15-oxokaur-16-
en-19-oic acid.
Conclusion: The main cytotoxic and DNA-damaging compound in ethanolic extracts of Xylopia aethiopica is ent-
15-oxokaur-16-en-19-oic acid.
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Background
Natural compounds have attracted considerable atten-
tion as preventive and therapeutic agents against cancer
[1]. Indeed, 74% of anticancer compounds are natural
products or their derivatives. According to the World
Health Organization (WHO), 80% of the population in
Africa and in some Asian countries still use plant pre-
parations to treat their illnesses, including cancer. The
cloves of the plant Xylopia aethiopica, a member of the
custard apple family, Annonaceae, are used as a spice in
various traditional dishes of Western and Central Africa.
The plant is also used in decoction to treat dysentery,
bronchitis, ulceration, skin infection and female sterility.
Several studies have shown that X. aethiopica extracts
possess antibacterial [2-5], antifungal [6] and anti-plas-
modial [7] activities. X. aethiopica extract contains an
antioxidant activity [8]; it also increases antioxidant
defense and protects rats from the adverse effects of
irradiation [9,10].
Although some extracts of this plant have antioxidant
properties, others have cytotoxic effects on a wide range
of cancer cell lines [11]. A recent study of various
Cameroonian spices [12] found that extract of X. aethio-
pica had cytotoxic activity against pancreatic and leuke-
mia cells sufficient for the plant to be considered a
potential source of cytotoxic compounds, according to
the plant-screening program of the National Cancer
Institute. In this report, we confirm the cytotoxic activ-
ity of X. aethiopica extract against a panel of cancer cell
lines and identify the main compound responsible for
this cytotoxic effect: ent-15-oxokaur-16-en-19-oic acid
(EOKA). Furthermore, we show that EOKA triggers
DNA damage and accumulation of the cells in the G1
phase of the cell cycle, followed by apoptosis.
Methods
Cells
Human cancer cell lines HCT116 (from a colorectal
cancer), U2OS (from an osteosarcoma) and SUM-159PT
(from a breast carcinoma) were cultured in DMEM. The
human pancreas adenocarcinoma cell line Capan-2 and
normal human skin primary fibroblasts (kindly provided
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12. Leukemia cell lines KG1a and U937 were grown in
IMDM. All culture media were supplemented with 10%
foetal calf serum, 100 u/ml penicillin and 100 μg/ml
streptomycin.
Extraction of X. Aethiopica
Dried fruits of X. aethiopica were collected from spice
vendors and the voucher specimen was identified at the
Cameroon National Herbarium. Dried fruits were
ground and extracted with 70% ethanol (100 mg/ml) for
2 h at 55°C with shaking every 30 minutes. The suspen-
sion was centrifuged at 4000 rpm for 10 minutes at 25°
C and the resulting supernatant extract was filtered and
stored at -20°C.
Stability assessment of the dried residue by LC/MS
Analytical liquid chromatography-mass spectrometry
(LC/MS) was carried out using Waters equipment: an
Xbridge C18 column (4.6 × 150 mm; 5 μm particle) for
separation, a Waters 2996 photodiode array detector
and a Waters 3100 mass detector (ES mode) for detec-
tion. Compounds were eluted with a gradient of water
and acetonitrile containing 0.05% of formic acid at a
rate of 17 ml/min. Ten microlitres of sample solution
were injected for each analysis.
Each LC/MS analysis was performed by injecting 500
μl of the X. aethiopica extract diluted with 500 μl
methanol. To check the stability of the extract, 20 ml
was dried under vacuum and the dried residue was
stored at room temperature for a week; it was then solu-
b i l i z e di nam i x t u r eo f2 0m lo fm e t h a n o la n d2m lo f
DMSO and analyzed by LC/MS. The resulting chroma-
tograms were identical, thus we conclude that the dried
residue is stable at room temperature.
HPLC fractionation of X. Aethiopica extract
Fractionation by HPLC was carried out using a Waters
Xbridge C18 column (19 × 150 mm; 5 μm particle), a
Waters 2996 photodiode array detector and a Waters
3100 mass detector (ES mode) for detection. Com-
pounds were eluted with a gradient of water and aceto-
nitrile at 1 ml/min. For each fractionation run, we
injected 350 μl of the solubilized residue in methanol/
DMSO as previously described.
Antiproliferative effect
Cell proliferation was assessed first by measurement of
viable cell number. HCT116, U2OS, SUM-159PT,
Capan-2, U937, KG1a and normal fibroblasts were
seeded in six-well plates (5 × 10
4 cells/well). Cells were
treated 24 hours later with X. aethiopica extract (25 μg
od dry powder per ml). After 4 days, the number of
cells in each well were counted on a cell counter.
The effect of X. aethiopica extract on cell proliferation
was also examined with the colorimetric reagent WST-1
(Roche). HCT116 cells were seeded into 96-well plates
(3 × 10
3 cells/well). After 24 h, increasing concentra-
tions of X. aethiopica extract or fractions obtained by
HPLC were added (six wells for each concentration).
After 4 days, cell viability was estimated according to
the manufacturer instructions, by measuring the optical
density of each well at 450 nm with a microplate reader
(Labsystems Multiskan).
Statistical tests were performed using Excel and
PRISM softwares.
Flow cytometry analysis
HCT116 cells were seeded in 60 mm plates (3 × 10
5
cells/plate) then treated 24 hours later with HPLC frac-
tions of X. aethiopica extract. Cells were harvested after
various times of treatment, fixed in ice-cold 70% etha-
nol, washed with PBS containing1% bovine serum albu-
min, and permeabilized with 0.25% Triton X-100 for 10
minutes. Cells were stained with a mouse monoclonal
antibody against phosphorylated g-H2AX (diluted 1/
1000; Upstate Biotechnology) followed by an Alexa 488-
conjugated anti-rabbit antibody (diluted 1/500;). DNA
was stained with propidium iodide (10 μg/ml) in the
presence of RNAase (10 μg/ml) for 1 h at room tem-
perature. The cell cycle phase and presence of g-H2AX
staining in individual cells was determined by flow cyto-
metry analysis (Accuri C6 cytometer, Cflow plus
software).
DAPI staining
U2OS cells were seeded in six-well plates (5 × 10
4 cells/
well) containing 12 mm coverslips and subsequently
treated for various times with peak 1 (20 μg/ml) or with
doxorubicin (10 mM). Cells were fixed with 4% formal-
dehyde (Diapath), permeabilized in 0.1% (w/v) Triton X-
100 for 5 min, washed in PBS and stained with DAPI.
Western blot analysis
U2OS cells were treated for various times with peak 1
(20 μg/ml). Cells were washed with PBS and lyzed in
ice-cold lysis buffer (Tris-HCl pH 7.5, 250 mM NaCl, 5
mM EDTA, 1 mM DTT, 0.1% Triton X-100, 50 mM
sodium fluoride, 1 mM sodium orthovanadate, 100 μg/
ml PMSF and TPCK, 50 μg/ml TLCK, 2 μg/ml leupep-
tin, 1 μg/ml pepstatin and 1 μg/ml aprotinin). Proteins
(100 μg) were separated by SDS-polyacrylamide gel elec-
trophoresis and transferred to nitrocellulose membranes
by semi-dry blotting. Membranes were hybridized with
antibodies against PARP (diuted 1/500; BD Pharmin-
gen), p21 (antibody sc-397, diluted 1/2000) and p53
(antibody sc-126, dilted 1/2000) (both from Santa Cruz
Biotechnology,). To control for equal loading, the
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(diluted 1/10000, Chemicon,).
Identification of the cytotoxic natural product
The chemical structure of the cytotoxic natural product
(peak 1 of the HPLC profile) was determined by mass
spectrometry (positive and negative electrospray ioniza-
tion) with a Waters 3100 mass detector and by NMR
analyses.
1H and
13 C spectra NMR spectra were carried
out in either methanol-d4 or deuteriochloroform as sol-
vents and were recorded with a Brucker Avance 300
spectrometer at 300 and 75 MHz, respectively. Carbon
multiplicities were determined by either DEPT135 or
Jmod experiments. Diagnostic correlations were deter-
mined by two-dimensional NMR correlation spectro-
scopy (COSY), heteronuclear multiple-quantum
correlation spectroscopy (HMQC) and heteronuclear
multiple-bond correlation spectroscopy (HMBC).
Results and discussion
We first evaluated the cytotoxic effect of four days con-
tinuous treatment with 25 μg/ml of X. aethiopica extract
in 70% ethanol on proliferation of various cancer cell
lines (Figure 1A). This treatment produced a highly sig-
nificant (p < 0.005) decrease in the number of cells in
all the lines we tested. The effect on normal fibroblasts
was less pronounced: 30% of cells survived the dose that
fully inhibited cancer cell line growth. We next used a
colorimetric cell proliferation assay with the reagent
WST-1 to determine the dose-response effect of X.
aethiopica extract on HCT116 colon cancer cells. The
extract induced a dose-dependent inhibition of cell via-
bility (IC50, 12 μg/ml; Figure 1B). We also determined
the effect of X. aethiopica extract on survival of imma-
ture (KG1a) and mature (U937) acute myeloid leukemia
cells. Although the extract decreased the survival of
both cell lines, the immature line KG1a (IC50, > 25 μg/
ml) was more resistant than the mature U937 cells
(IC50, 7.5 μg / m l ) .S i n c eK G 1 al e u k e m i ac e l l sh a v e
increased ability to carry out DNA repair [13], our data
suggested that DNA repair might play a crucial role in
mitigating the cytotoxic effect of X. aethiopica.
O u rd a t ai n d i c a t et h a tX .a e t h i o p i c ae x t r a c ti sc y t o -
toxic to cells from a variety of cancers: carcinoma,
osteosarcoma and leukemia. These data confirm and
extend those of Kuete et al. [12], who reported that,
among the 34 Cameroonian spices and plant tested, a
crude extract of X. aethiopica was one of the most cyto-
toxic against MiaPaCa-2 pancreatic cancer cell line and
CCRF-CEM leukemia cells. Another study characterized
the antiproliferative effect of X. aethiopica extract on
human cervical cancer cells [14].
Considering the potency and relative selectivity of X.
aethiopica extract for cancer cells, we decided to
characterize further the cytotoxic activity in the extract.
To this end, we analysed the extract by LC/MS (Figure
2A). From the chromatogram, we identified four frac-
tions of interest: area 1 (retention time, 3-11 min), peak
1 (retention time, 11.4 min), peak 2 (retention time,
13.2 min) and area 2 (retention time, 14-20 min). We
then isolated these fractions at a preparative scale by
fractionating 2 ml of the residue solubilized in metha-
nol/DMSO.
We assayed the cytotoxicities of the four selected frac-
tions (i.e., area 1, area 2, peak 1 and peak 2) against
HCT116 cells (Figure 3). Area 1 and peak 2 were devoid
of cytotoxic activity and area 2 had only a slight cyto-
toxic effect at high dose (20 μg/ml). By contrast, peak 1
Figure 1 The antiproliferative effect of extracts of X. aethiopica
on various cancer cell lines.( A) The indicated cell lines were
treated with either 70% ethanol (control vehicle) or 25 μg/ml X.
aethiopica extract for 4 days. Cell numbers were counted and
normalized to the control value. Student’s t-test gives a p-value <
0.005 for all cell lines. (B) Dose-response curves for the effect of X.
aethiopica extracts on the viability of HCT116, KG1a, U937 cells and
normal fibroblasts. Cells were treated with various concentrations of
X. aethiopica extract for 4 days and cell viability was determined
using a WST-1 assay (triplicate determination). The values are the
means of three independent experiments and the error bars
represent the standard deviation.
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Page 3 of 8Figure 2 LC/MS fractionation of X. aethiopica extract and structure of EOKA, the active compound in peak 1.( A) High-performance
liquid chromatography (C18 HPLC column) profile of 70% ethanol extract (ES-TIC: mass 100 to 600, and UV: diode array 210-400 nm). Selected
areas 1 and 2, and peaks 1 and 2 are indicated. (B) Chemical structure of ent-15-oxokaur-16-en-19-oic acid (EOKA).
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Page 4 of 8Figure 3 The antiproliferative effects of various LC/MS fractions of X. aethiopica extract. Dose-response curves showing the effects of the
four fractions of X. aethiopica extract obtained by HPLC (Figure 2) on HCT116 cell viability. Cells were treated for 4 days with increasing
concentration of the various fractions (area 1, area 2, peak 1, peak 2) and cell viability was determined by WST-1 assay (triplicate determination).
The values are the means of three independent experiments and the error bars represent the standard deviation.
Figure 4 The effect of peak 1 on DNA damage and the cell cycle. Flow cytometry analysis of DNA content (top panel) and gH2AX
expression (lower panel) in U2OS cells after treatment with fractions of X. aethiopica extract. The cells were treated for 24 h with 20 μg/ml of
the various fractions. The percentage of cells with G1 and G2/M DNA content are indicated. The percentage of gH2AX- positive cells above the
threshold line indicates the amount of DNA damage.
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Thus, peak 1 was selected for further study.
Many of the commonly used cancer chemotherapeutic
drugs exert their cytotoxic effects by inducing DNA
damage, which activate cell cycle checkpoints that coor-
dinate cell-cycle progression with DNA repair [15]. To
determine whether the cytotoxic effect of peak 1 was
due to DNA damage and activation of cell cycle check-
points, we used biparametric flow cytometry analysis of
DNA damage and DNA content in U2OS cells. We
used immunochemical staining for histone H2AX phos-
phorylation at Ser139 (g-H2AX) as a measure of DNA
damage and propidium iodide staining to monitor DNA
content of control cells and cells treated with 20 μg/ml
of peak 1, peak 2, area 1 and area 2 (Figure 4). An
increase in H2AX phosphorylation was detected by the
presence of cells with higher signal from g-H2AX than
in control cells. Peak 1 induced accumulation of cells
with more DNA damage than control cells, whereas no
significant change in the proportion of cells with DNA
damage was observed after treatment with area 1, area 2
or peak 2. Indeed, whereas less than 1% of control cells
presented DNA damage, 25% of peak 1-treated cells had
damaged DNA. Furthermore, our results show that peak
1 DNA damaging activity was associated with an accu-
mulation of U2OS cells in the G1-phase of the cell
cycle.
To characterize in more detail peak 1-induced DNA
damage, we performed a kinetic study (Figure 5A). DNA
damage could be detected within 4 h after treatment of
Figure 5 The kinetics of peak 1-induced DNA damage.( A) DNA damage in treated with peak 1 (20 μg/ml) or with for various times up to 48
h. Bars represent the mean of two independent experiments. (B) Bivariate analysis of DNA damage (gH2AX) and DNA content (2n, 4n) after
treatment with 20 μg/ml of peak-1 for 24 h.
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DNA content and g-H2AX staining after 24 h treatment
with peak 1 (20 μg/ml) (Figure 5B).
Screening of some medicinal plants commonly used in
Nigeria found that X. aethiopica had mutagenic activity
[16]. This mutagenic activity could be due to the DNA
damage we found induced by peak 1 in the X. aethiopica
extract. raising the issue of the use of this medicinal plant
as spice. By contrast, other studies have found that X.
aethiopica extract protects rats against the adverse effects
of g irradiation [9,10], suggesting that X. aethiopica extract
contains both DNA damaging agents and protecting
agents against the DNA damaging effect of irradiation.
It has previously been reported that X. aethiopica fruit
extract induces cell death by apoptosis in the cervical
cancer cell line C-33A [14]. We examined whether peak
1 had this effect on U2OS cells (20 μg/mL) when com-
pared to treatment with the chemotherapy drug doxoru-
bicin. Cells treated with peak 1 displayed chromatin
condensation and nuclear shrinkage, as observed by
DAPI staining, similar to that seen after treatment with
doxorubicin (Figure 6A). To confirm that the condensed
chromatin and nuclear shrinking was due to apoptosis,
we monitored the cleavage of PARP (115 kDa) and the
appearance of the 85 kDa fragment (Figure 6B). A 85
kDa band was observed when U2OS cells were treated
for 24 h with peak 1. Similarly, PARP cleavage was also
observed after treatment of the cells with doxorubicin.
These data indicate that peak 1 may be responsible for
the apoptotic activity of X. aethiopica extract. The
Figure 6 The apoptosis-inducing effect of peak 1.( A) DAPI staining of U2OS cells after 24 h treatment with peak 1 (20 μg/mL) or 10 nM
doxorubicin. The images are representative of three independent experiments. The mean percentage of apoptotic cells is indicated. (B) Western
blot analysis of PARP after treatment of U2OS cells with peak 1 (20 μg/ml) or doxorubicin (10 nM) for 8, 24 and 48 h. Full-length 115 kDa PARP
and its 85 kDa proteolytic fragment are shown. Actin is presented as a control for equal loading.
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induced cell cycle arrest and apoptosis will require
further investigation.
To determine unambiguously the chemical structure
of the active compound corresponding to peak 1 of
HPLC profile, we first analyzed our mass spectrometry
data and found a molecular weight of 316, possibly indi-
cating a C20H28O3 diterpene. We elucidated the struc-
ture by using standard and multi-dimensional NMR
spectroscopy. Finally, we compared our
1Ha n d
13 C
NMR data with those of the known compound ent-15-
oxokaur-16-en-19-oic acid (EOKA) (Figure 2B) and
proved to be identical to the literature data [17-19].
Taken together, our data demonstrate that EOKA is
the main cytotoxic compound in extract of X.
aethiopica.
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